analyst
PH
NASDAQ · PHAT
Phathom Pharmaceuticals, Inc.
Healthcare · Biotechnology
$8.16
Down-$0.47 (-5.76%)
Updated Sep 16, 2026, 9:56 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.04B
- P/E ratio
- -3.89
- Dividend yield
- 0.00%
- 52-week range
- $8.07 – $18.31
- Volume
- 1.64M
- Avg. volume
- 1.06M
Price performance
PHAT price history
1M range · 0 trading sessions · Daily adjusted prices
PHAT does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest PHAT news
The latest Smart Investors Daily articles mentioning PHAT.
Stock researchCompany · Financials
Loading stock research…